Dr. Ekaterina Kuznetsova
Ekaterina Kuznetsova earned her Bachelor of Science in Molecular Biology from the University of Toronto in 2002. She received her PhD in 2009 from the University of Toronto, focusing on areas of proteomics and biochemistry. She continued her training as a postdoctoral scientist at the Structural Genomics Consortium (MBB/Karolinska Institute, Sweden), working on evaluation of PARP inhibitors. After that, Dr. Kuznetsova worked at SGC Toronto, University of Toronto as a research associate concentrating in epigenetic assay development and high-throughput screening for early stage drug discovery.